Datex-Ohmeda, Inc., a prominent name in the medical technology sector, is headquartered in the United States. Founded in the late 20th century, the company has established itself as a leader in anaesthesia delivery systems and patient monitoring solutions. With a strong operational presence across North America and Europe, Datex-Ohmeda is renowned for its innovative products that enhance patient safety and improve clinical outcomes. The company’s core offerings include advanced anaesthesia machines, monitoring devices, and integrated solutions that streamline healthcare workflows. What sets Datex-Ohmeda apart is its commitment to quality and precision, ensuring that healthcare professionals have access to reliable tools in critical care environments. With a solid market position and a history of notable achievements, Datex-Ohmeda continues to shape the future of medical technology, making significant contributions to the healthcare industry.
How does Datex-Ohmeda, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Datex-Ohmeda, Inc.'s score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Datex-Ohmeda, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of GE HealthCare Technologies Inc., which may influence its climate commitments and reporting practices. As part of its corporate family, Datex-Ohmeda's climate initiatives and targets are likely aligned with those of GE HealthCare Technologies Inc. However, specific reduction targets or achievements have not been disclosed for Datex-Ohmeda. The absence of documented reduction initiatives suggests that the company may still be in the process of establishing its own climate strategy or reporting framework. In the context of the broader industry, companies are increasingly adopting science-based targets and committing to net-zero emissions. Datex-Ohmeda's alignment with GE HealthCare Technologies Inc. may provide a pathway for future climate commitments, particularly as the healthcare sector faces growing pressure to address sustainability and carbon emissions. Overall, while specific emissions data and reduction targets for Datex-Ohmeda remain unavailable, the company's affiliation with GE HealthCare Technologies Inc. positions it within a framework that prioritises climate action and sustainability.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 137,254,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 192,207,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Datex-Ohmeda, Inc.'s Scope 3 emissions, which decreased by 4% last year and decreased by approximately 9% since 2022, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Downstream Leased Assets" being the primary emissions source at 68% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Datex-Ohmeda, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.